Boston Scientific has agreed to acquire the rest of Bolt Medical, the developer of an intravascular-lithotripsy, or IVL, laser-based platform for the treatment of coronary and peripheral artery ...
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced ...